Lumida
/VRDN
⌘K
Viridian Therapeutics Inc

Viridian Therapeutics Inc

VRDN
$21.24USD-4.71%-1.05 today

MARKET CAP

2.4B

P/E (TTM)

FWD P/E

DAY RANGE

$21 – $23

52W RANGE

$13
$34

AI Summary

Stalk
Sell NowMedium

VRDN has broken a key support cluster and entered a Stage 3 distribution context reinforced by the Support Failure pattern, establishing a bearish medium-term bias. Short-term momentum is confirming follow-through below the EMAs, making now an opportune time to sell into any relief rallies into the 23.10–23.30 resistance zone under the speculative strategy’s high-selectivity framework.

  • VRDN001 Phase III shows 75% proptosis response vs 44% for Tepezza
  • Q4 2023 cash of $613M sustains runway into mid-2026
  • Q1 2024 R&D spend at $50.7M vs $17.7M prior year escalates cash burn
Full analysis →

No politician trades found for VRDN.